What Are Antibody-drug Conjugates?
Antibody-drug conjugates, or ADCs, are increasingly common cancer therapies. But what are they? How do they work? And how...
Cancer Research CatalystThe Official Blog of the American Association for Cancer Research
Antibody-drug conjugates, or ADCs, are increasingly common cancer therapies. But what are they? How do they work? And how...
The term “hackathon” may conjure up images of beanie-wearing coders working in dark basements, trying to build a new...
What comes to mind when you think of a fungus? A mushroom? A case of athlete’s foot or ringworm? ...
By Kaleem Zaidi, PhDAACR Executive Office The year 2022 marked significant progress against cancer, thanks to advances in cancer...
With Thanksgiving behind us here in the United States, the holiday season is in full swing. So, grab some...
You’re feeling sluggish. You eat a banana. You feel better. We all know that a calorie-rich snack can provide...
By Steven Grossman, MD, PhD Pancreatic cancer is an outlier among cancers, fiercely resisting almost every scientific advance researchers...
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today Nearly 85 percent of all cancer deaths in the...
As COVID-19 cases and death rates fall, and in-person activities resume, cancer centers once again fill their beds with...
As the candy supply dwindles, and the Halloween sugar rush tapers off, get re-energized by the latest edition of...
The AACR is pleased to offer the Global Scholar-in-Training Awards (GSITA) to eligible early-career investigators in countries building cancer...